Abstract: The present invention provides formulations comprising anti-TIGIT antibodies with CDRs identical to those shown in Figure 3 (i.e., CDRs identical to those for CPA.9.086.H4(S241P), as described herein.
| # | Name | Date |
|---|---|---|
| 1 | 202417100260-STATEMENT OF UNDERTAKING (FORM 3) [18-12-2024(online)].pdf | 2024-12-18 |
| 2 | 202417100260-REQUEST FOR EXAMINATION (FORM-18) [18-12-2024(online)].pdf | 2024-12-18 |
| 3 | 202417100260-PRIORITY DOCUMENTS [18-12-2024(online)].pdf | 2024-12-18 |
| 4 | 202417100260-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [18-12-2024(online)].pdf | 2024-12-18 |
| 5 | 202417100260-FORM 18 [18-12-2024(online)].pdf | 2024-12-18 |
| 6 | 202417100260-FORM 1 [18-12-2024(online)].pdf | 2024-12-18 |
| 7 | 202417100260-DRAWINGS [18-12-2024(online)].pdf | 2024-12-18 |
| 8 | 202417100260-DECLARATION OF INVENTORSHIP (FORM 5) [18-12-2024(online)].pdf | 2024-12-18 |
| 9 | 202417100260-COMPLETE SPECIFICATION [18-12-2024(online)].pdf | 2024-12-18 |
| 10 | 202417100260-FORM-26 [18-02-2025(online)].pdf | 2025-02-18 |
| 11 | 202417100260-FORM 3 [30-05-2025(online)].pdf | 2025-05-30 |
| 12 | 202417100260-Proof of Right [12-06-2025(online)].pdf | 2025-06-12 |
| 13 | 202417100260-FORM 13 [12-06-2025(online)].pdf | 2025-06-12 |
| 14 | 202417100260-AMMENDED DOCUMENTS [12-06-2025(online)].pdf | 2025-06-12 |